PMID- 19408052 OWN - NLM STAT- MEDLINE DCOM- 20090819 LR - 20151119 IS - 1534-4681 (Electronic) IS - 1068-9265 (Linking) VI - 16 IP - 7 DP - 2009 Jul TI - Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer. PG - 2052-7 LID - 10.1245/s10434-009-0474-9 [doi] AB - BACKGROUND: Lymph node metastasis is the most important factor to consider when deciding on the modality of resection in patients with early gastric cancer. The aim of the present study was to assess the relationship between preoperative serum angiopoietin-2, a lymphangiogenic growth factor, and lymph node metastasis in patients with early gastric cancer. METHODS: A total of 62 preoperative serum samples from patients diagnosed with early gastric adenocarcinoma, and 30 serum samples from healthy donors were obtained. The serum levels of angiopoietin-2 (Ang-2) were quantified by immunoassay. Intra- and peritumor lymphatic vessel density (I-LVD and P-LVD) were counted after immunohistochemical staining. The relationship between the serum Ang-2 levels and other prognostic variables (tumor size, histological type, depth of tumor invasion, I-LDV, P-LDV, presence of lymph node involvement, and distant metastasis) were then examined by univariate and multivariate linear regression analyses. RESULTS: The median serum levels of Ang-2 in patients were higher than those of healthy controls [311.1 ng/mL, interquartile range (IQR) 256.7-311.1 ng/mL versus 286.5 ng/mL, IQR 226.9-286.5 ng/mL; Mann-Whitney test, P = 0.016]. Eight patients had metastatic lymph nodes; the Ang-2 levels from the patients with metastatic lymph nodes were higher than from those with negative lymph nodes (297.5 ng/mL, IQR 251.1-385.8 ng/mL versus 416.0 ng/mL, IQR 337.1-485.5 ng/mL; Mann-Whitney test, P = 0.019). Elevated serum Ang-2 levels were associated with positive lymph node involvement and this finding was significant on univariate (P = 0.008) and multivariate logistic regression analysis (P = 0.011). CONCLUSION: Serum Ang-2 levels were clinically useful markers for lymph node metastasis in patients with early gastric cancer. FAU - Jo, Min Jung AU - Jo MJ AD - Gastric Cancer Branch, National Cancer Center, Goyang-si, Gyeonggi-do, Korea. FAU - Lee, Jun Ho AU - Lee JH FAU - Nam, Byung-Ho AU - Nam BH FAU - Kook, Myeong Cherl AU - Kook MC FAU - Ryu, Keun Won AU - Ryu KW FAU - Choi, Il Ju AU - Choi IJ FAU - Kim, Young-Woo AU - Kim YW FAU - Bae, Jae-Moon AU - Bae JM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090430 PL - United States TA - Ann Surg Oncol JT - Annals of surgical oncology JID - 9420840 RN - 0 (Angiopoietin-2) RN - 0 (Biomarkers, Tumor) SB - IM MH - Adenocarcinoma/blood/*pathology/surgery MH - Aged MH - Angiopoietin-2/*blood MH - Biomarkers, Tumor/*blood MH - Female MH - Humans MH - Lymph Nodes/*pathology MH - Lymphatic Metastasis MH - Lymphatic Vessels/pathology MH - Male MH - Middle Aged MH - Stomach Neoplasms/blood/*pathology/surgery EDAT- 2009/05/02 09:00 MHDA- 2009/08/20 09:00 CRDT- 2009/05/02 09:00 PHST- 2009/02/14 00:00 [received] PHST- 2009/03/25 00:00 [accepted] PHST- 2009/05/02 09:00 [entrez] PHST- 2009/05/02 09:00 [pubmed] PHST- 2009/08/20 09:00 [medline] AID - 10.1245/s10434-009-0474-9 [doi] PST - ppublish SO - Ann Surg Oncol. 2009 Jul;16(7):2052-7. doi: 10.1245/s10434-009-0474-9. Epub 2009 Apr 30.